loader2
Login Open ICICI 3-in-1 Account
  • Text Size
  • Text to Speech
  • Color Contrast
  • Pause Animations

Apr 30, 2026

loader2

Open ICICI 3-in-1 Account

Manage your Savings, Demat and Trading Account conveniently at one place

What is Nifty 200?

Company Name PE Mcap/Sales P/BV EV/EBIDTA D/E ROCE ROE
Abbott India Ltd 35.46 8.38 13.48 34.82 0.04 44.95 35.66
Cipla Ltd 23.34 3.84 3.21 15.12 0.02 23.15 18.28
J B Chemicals & Pharmaceuticals Ltd 43.62 8.39 8.62 32.58 0.06 26.42 20.75
Dr Reddys Laboratories Ltd 19.99 3.38 3.07 13.57 0.11 23.05 18.53
Lupin Ltd 22.56 4.64 5.37 20.32 0.27 20.88 21.00
Torrent Pharmaceuticals Ltd 62.44 12.32 16.76 43.99 0.50 25.84 26.46
Ipca Laboratories Ltd 41.28 4.35 5.23 26.49 0.21 17.12 13.61
Sun Pharmaceutical Industries Ltd 39.61 8.25 5.58 28.13 0.04 19.52 16.16
Aurobindo Pharma Ltd 23.16 2.54 2.30 13.30 0.24 14.16 11.15
Wockhardt Ltd -2,249.35 7.52 4.97 80.06 0.57 3.87 -1.48
Ajanta Pharma Ltd 34.78 7.59 8.17 27.51 0.01 31.98 25.02
Gland Pharma Ltd 34.05 5.14 3.02 19.28 0.00 15.83 11.62
Biocon Ltd 92.67 3.82 1.54 21.28 0.84 6.86 6.90
Alkem Laboratories Ltd 26.67 4.98 4.84 26.35 0.13 20.03 19.88
Glenmark Pharmaceuticals Ltd 63.74 5.10 7.09 38.26 0.22 18.48 15.79
Zydus Lifesciences Ltd 17.85 3.86 3.55 12.36 0.09 24.56 21.08
Divis Laboratories Ltd 69.67 18.45 11.20 57.32 0.00 20.42 15.35
Mankind Pharma Ltd 51.43 7.60 6.07 34.45 0.37 16.04 14.83
Laurus Labs Ltd 70.59 10.68 12.37 60.46 0.62 8.80 7.36
Piramal Pharma Ltd -66.08 2.35 2.64 21.74 0.60 6.43 1.14

Other Indices

INDEX NAME MARKET VALUE 52W HIGH 52W LOW
Nifty Next 50 69643.90
(-1.2449%)
71536.80 59896.10
Nifty Bank 54863.35
(-0.9751%)
61764.85 49954.85
Nifty 50 23997.55
(-0.7449%)
26373.20 22182.55
Nifty 100 24896.0
(-0.8368%)
26975.15 22720.45
BSE SmallCap 46825.31
(0.0%)
55792.26 45369.54
BSE Sensex 76913.50
(-0.7521%)
86159.02 71545.81
BSE MidCap 44246.27
(0.0%)
47764.30 41047.86
BSE 100 25392.58
(-0.8025%)
27621.72 23249.92

Nifty Pharma

The NIFTY Pharma Index reflects the behaviour and performance of the pharmaceutical sector in India. The index has a maximum of 20 stocks since the last amendment effective from 30th September 2021. The NIFTY Pharma stocks are calculated using the free-float market capitalization method and can be used for benchmarking fund portfolios, among other utilization for investors. The index was launched in July 2005; the base date being 1st January 2001 with a base value of 1000. Index is re-balanced on semi-annual basis. The cut-off date is January 31 and July 31 of each year. When rebalancing, the weightage of each stock in the index is calculated such that no single stock has a weightage of more than 33%, and that of top 3 stocks cumulatively shall not be more than 62%.

News

Dr Lal Pathlabs fixes record date for final dividend

Dr Lal Pathlabs has fixed 26 June 2026 as record date for payment of final dividend of Rs 4 per equity sh...

Apr 30, 2026 16:13
Hindustan Unilever fixes record date for final dividend

Hindustan Unilever has fixed 23 June 2026 as record date for payment of final dividend of Rs 22 per equit...

Apr 30, 2026 11:28
Board of Sterlite Technologies does not recommend dividend

The board of Sterlite Technologies at its meeting held on 29 April 2026 has not recommended any dividend ...

Apr 30, 2026 09:12
Geojit Financial Services fixes record date for final dividend

Geojit Financial Services has fixed 10 July 2026 as record date for payment of final dividend of Rs 1.50 ...

Apr 29, 2026 19:49
Indian Bank fixed record date for dividend

Indian Bank has fixed 10 June 2026 as record date for payment of dividend. ...

Apr 29, 2026 14:54
Granules India fixes record date for final dividend

Granules India has fixed 30 July 2026 as record date for final dividend of Rs 1.75 per share for FY 2026....

Apr 29, 2026 14:47
Disclaimer

ICICI Securities Ltd. Registered office of ICICI Securities is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Mumbai - 400025, India, Tel No:- 022 - 2288 2460, 022 - 2288 2470. ICICI Securities is a Member of National Stock Exchange of India Ltd (Member Code:-07730) and BSE Ltd (Member Code :103) and having SEBI registration no. INZ000183631. SEBI research analyst Registration no.-INH000000990. Name of the Compliance officer (broking): Mr. Anoop Goyal, Contact number: 022-40701000, E-mail address: complianceofficer@icicisecurities.com. Investment in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein above shall not be considered as an invitation or persuasion to trade or invest.  ICICI Securities and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. The non-broking products / services like Mutual Funds, Insurance, FD/ Bonds, loans, PMS, Tax, Elocker, NPS, IPO, Research, Financial Learning etc. are not exchange traded products / services and ICICI Securities Ltd. is just acting as a distributor/ referral Agent of such products / services and all disputes with respect to the distribution activity would not have access to Exchange investor redressal or Arbitration mechanism.